MP-CPI-23-003: National Lupus Outreach and Clinical Trial Education Program
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Office of the Assistant Secretary for Health notices from 2023.
Office of the Assistant Secretary for Health offered grants of up to $500,000 (at least $300,000) to nonprofits, colleges and universities, state and local governments and tribes. It expected to make about 6 awards worth $2.0 million in total. Applications closed on August 1, 2023.
From the official notice on Grants.gov, last changed June 16, 2023. Checked November 7, 2026.
- Award ceiling$500,000
- Award floor$300,000
- Total funding$2.0 million
- Expected awards6
- Cost sharingNot required
- Funding typeGrant
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| MP-CPI-26-001 | June 10, 2026 | Closed July 10, 2026 | Closed |
| MP-CPI-21-005 | April 26, 2021 | Closed June 29, 2021 | Closed |
Key dates
| Posted | June 16, 2023 |
|---|---|
| Deadline | August 1, 2023 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments and tribes.
All 12 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
Is this a realistic fit?
- Past Community Programs to Improve Minority Health awards averaged $2.0 million; this notice allows up to $500,000 per award.
- Most of the program's money (50% over five years) went to state and local governments.
- No cost sharing or match is required.
What the grant funds
The HHS Office of Minority Health (OMH) anticipates funding projects to demonstrate the effectiveness of interventions for increasing racial and ethnic minority enrollment and retention in lupus-related clinical trials. Projects are intended to identify and sustain effective interventions that advance clinical trial diversity and to ultimately result in reduced lupus-related health disparities experienced by racial and ethnic minority populations. Black women are three times more likely to develop lupus than their White counterparts, with Hispanic, Asian, and Native American populations also at an increased risk for developing lupus. African Americans account for 43% of all lupus cases, but African American enrollment in lupus clinical trials stands at 14%. Without enrollment in clinical trials that reflect the patient population the drug is intended to treat, a drug may be less effective or not effective at treating the disease in a large number of patients. Increasing minority participation in lupus clinical trials is important for addressing lupus-related racial and ethnic health disparities. Recipients will be expected to sustain increased enrollment of racial and ethnic minorities in lupus-related clinical trials through outreach and education interventions, and public-private and community partnerships. Recipients also will assess the impact of project findings by implementing a process and outcomes evaluation for dissemination to diverse stakeholders.
Who has won Community Programs to Improve Minority Health grants before
From fiscal 2021 to 2025, Community Programs to Improve Minority Health (93.137) awarded $440 million across 224 grant awards, an average of $2.0 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Morehouse School of Medicine, Inc. | Georgia | 4 | $27.9 million |
| American Heart Association, Inc. | Texas | 1 | $19.5 million |
| University of Hawaii | Hawaii | 2 | $8.0 million |
| Oklahoma State University | Oklahoma | 2 | $7.8 million |
| Washington, County of | Oregon | 2 | $7.1 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is MP-CPI-23-003 still open?
No. It closed on August 1, 2023.
Who can apply for National Lupus Outreach and Clinical Trial Education Program?
Office of the Assistant Secretary for Health accepted applications from nonprofits, colleges and universities, state and local governments and tribes.
What is the deadline for National Lupus Outreach and Clinical Trial Education Program?
Closed August 1, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $500,000 each. About $2.0 million in total across about 6 awards.
Who has won Community Programs to Improve Minority Health grants before?
The largest recipients over five fiscal years were The Morehouse School of Medicine, Inc., American Heart Association, Inc., University of Hawaii. The program made 224 awards worth $440 million in that time.
Similar open grants
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)